Eledon Pharmaceuticals
ELDN
ELDN
31 hedge funds and large institutions have $15.9M invested in Eledon Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-1
Holders Change %
-3.13%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
11
Closed
3
Calls
$57K
Puts
–
Net Calls
+$57K
Net Calls Change
+$126K
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$79K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$11K |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$314K |
4 |
4
Morgan Stanley
New York
|
$5K |